Search results
Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML
Morningstar· 6 days agoKura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today ...
SG Americas Securities LLC Has $57,000 Stake in Nektar Therapeutics (NASDAQ:NKTR)
ETF DAILY NEWS· 7 days agoSG Americas Securities LLC lifted its holdings in Nektar Therapeutics (NASDAQ:NKTR – Free Report) by 30.6% during the 4th quarter, according to its most recent filing with the Securities and ...
2024 ASCO | Mabwell to Present Clinical Data of 9MW2821 in Multiple Advanced Solid Tumor
FOX 59 Indianapolis· 3 days agoMabwell (688062.SH), an innovation-driven biopharmaceutical company with an entire industry chain,...
Nisa Investment Advisors LLC Has $29,000 Position in Janux Therapeutics, Inc. (NASDAQ:JANX)
ETF DAILY NEWS· 6 days agoNisa Investment Advisors LLC lifted its position in Janux Therapeutics, Inc. (NASDAQ:JANX – Free Report) by 10,740.0% during the fourth quarter, according to its most recent 13F filing with ...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against...
Morningstar· 4 days agoBragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Checkpoint Therapeutics ...
Precigen to Present Late-breaking Abstract for Pivotal Phase 2 Study Data for PRGN-2012 AdenoVerse...
StreetInsider· 4 days agoGERMANTOWN, Md., April 24, 2024 /PRNewswire/ --...
Orthopaedics Resident Left Soaring Examples in Her Life
UB Reporter· 4 days agoThe late Jessica “Jessi” Block, MD, who died last November, exemplified the epitome of courageousness during her lengthy battle with an aggressive form of oral cancer. A trainee ...